These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 33206653)
21. Tissue Is the Issue, Even During a Pandemic. Shah KS; Moslehi JJ; Fang JC Circulation; 2020 Aug; 142(5):423-425. PubMed ID: 32539523 [No Abstract] [Full Text] [Related]
28. Exosome-Based Cell-Free Therapy in COVID-19-Associated Severe Pneumonia: A New Lease of Life for Cell Therapy? Monsel A; Sitbon A Chest; 2023 Dec; 164(6):1343-1344. PubMed ID: 38070953 [No Abstract] [Full Text] [Related]
29. Obesity and immunodeficiencies are the main pre-existing conditions associated with mild to moderate COVID-19 in children. Leon-Abarca JA Pediatr Obes; 2020 Dec; 15(12):e12713. PubMed ID: 32789994 [No Abstract] [Full Text] [Related]
30. SIGNs of COVID-19: Is evidence contagious? Boot MJ; Timoney A J R Coll Physicians Edinb; 2022 Mar; 52(1):10-11. PubMed ID: 36146957 [No Abstract] [Full Text] [Related]
31. Obesity and COVID-19: Time to Take Action. Akbas F; Usta Atmaca H Obes Facts; 2020; 13(6):608-610. PubMed ID: 33166962 [No Abstract] [Full Text] [Related]
32. The Inadequacy of the Physical Signs as Indicating the Gravity of a Pneumonia. Smith AH Trans Am Climatol Assoc; 1900; 16():200-3. PubMed ID: 21408276 [No Abstract] [Full Text] [Related]
33. The association between body mass index class and coronavirus disease 2019 outcomes. Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD Int J Obes (Lond); 2021 Mar; 45(3):700-705. PubMed ID: 33221825 [TBL] [Abstract][Full Text] [Related]
35. Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis. Chu Y; Yang J; Shi J; Zhang P; Wang X Eur J Med Res; 2020 Dec; 25(1):64. PubMed ID: 33267871 [TBL] [Abstract][Full Text] [Related]
36. Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19. Ji D; Zhang M; Qin E; Zhang L; Xu J; Wang Y; Cheng G; Wang F; Lau G Metabolism; 2021 Feb; 115():154437. PubMed ID: 33220249 [No Abstract] [Full Text] [Related]
37. Weight Gain in a Sample of Patients Affected by Overweight/Obesity with and without a Psychiatric Diagnosis during the Covid-19 Lockdown. Marchitelli S; Mazza C; Lenzi A; Ricci E; Gnessi L; Roma P Nutrients; 2020 Nov; 12(11):. PubMed ID: 33207742 [TBL] [Abstract][Full Text] [Related]
38. Significant Correlations of SARS-CoV-2 Infection With Prevalence of Overweight/Obesity and Mean Body Mass Index in the SARS-CoV-2 Endemic Countries. Yanai H Cardiol Res; 2020 Dec; 11(6):412-414. PubMed ID: 33224388 [No Abstract] [Full Text] [Related]